We are live on ! Find out more
TLOG

TetraLogic Pharmaceuticals Corporation
TLOG

Delisted

TLOG was delisted on the 3rd of November, 2016.

Back to rankings

33 hedge funds and large institutions have $14.7M invested in TetraLogic Pharmaceuticals Corporation in 2015 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 2

25% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 8

6% more funds holding

Funds holding: 31 → 33 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

48% less capital invested

Capital invested by funds: $28.3M → $14.7M (-$13.6M)

Holders
33
Holders Change
+2
Holders Change %
+6.45%
% of All Funds
0.89%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
9
Reduced
2
Closed
8
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$7K

Top Buyers

Rank Fund Capital Flow
1
First Eagle Investment Management
First Eagle Investment Management
New York
+$651K
2
FWC
First Washington Corp
Washington
+$402K
3
Lazard Asset Management
Lazard Asset Management
New York
+$279K
4
Millennium Management
Millennium Management
New York
+$182K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$163K

Top Sellers

Rank Fund Capital Flow
1
KCM
Kingdon Capital Management
New York
-$1.16M
2
EA
Emerald Advisers
Pennsylvania
-$662K
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$550K
4
IHM
Iguana Healthcare Management
New York
-$438K
5
PVI
Pura Vida Investments
New York
-$353K
Name Holding Trade Value Shares
Change 		Change in
Stake
BWA
26
Burt Wealth Advisors
Maryland
$6K – – –
BIM
27
BlackRock Investment Management
Delaware
$3K +$2.52K +817 +122%
Bank of America
28
Bank of America
North Carolina
$3K +$4.5K +1,459 New
Bank of Montreal
29
Bank of Montreal
Ontario, Canada
$2K – – –
PNC Financial Services Group
30
PNC Financial Services Group
Pennsylvania
$2K – – –
Wells Fargo
31
Wells Fargo
California
$2K – – –
BA
32
BlackRock Advisors
Delaware
$1K +$1.87K +606 New
Manulife (Manufacturers Life Insurance)
33
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$6 +$8.24K +2,672 New
KCM
34
Kingdon Capital Management
New York
– -$1.16M -263,827 Closed
EA
35
Emerald Advisers
Pennsylvania
– -$662K -163,540 Closed
Point72 Asset Management
36
Point72 Asset Management
Connecticut
– -$550K -125,559 Closed
IHM
37
Iguana Healthcare Management
New York
– -$438K -100,000 Closed
PVI
38
Pura Vida Investments
New York
– -$353K -80,500 Closed
WA
39
Whitebox Advisors
Minnesota
– -$218K -49,800 Closed
NIP
40
Nicholas Investment Partners
California
– -$84K -19,188 Closed
Northern Trust
41
Northern Trust
Illinois
– -$46K -10,554 Closed
1
2

TLOG Hedge Fund Activity: Q2 2015 in Review

33 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in TetraLogic Pharmaceuticals Corporation (TLOG) for Q2 2015, worth a combined $14.7M — down 48% from $28.3M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TLOG positions and 8 closed out — a net gain of 2 holders — while 9 added to existing stakes and 2 trimmed.

The largest buyer was First Eagle Investment Management, adding an estimated $651K. The largest seller was Kingdon Capital Management, exiting entirely with an estimated $1.16M sold.

  • 33 institutional investors held TetraLogic Pharmaceuticals Corporation (TLOG) as of Q2 2015, up from 31 in Q1 2015.
  • Funds reported $14.7M of TetraLogic Pharmaceuticals Corporation stock for Q2 2015, down 48% quarter-over-quarter.
  • 10 funds opened new TetraLogic Pharmaceuticals Corporation positions in Q2 2015 and 8 closed out, a net change of +2 holders.
  • The largest TetraLogic Pharmaceuticals Corporation buyer in Q2 2015 was First Eagle Investment Management, an estimated $651K added.
  • The largest TetraLogic Pharmaceuticals Corporation seller in Q2 2015 was Kingdon Capital Management, an estimated $1.16M sold.

Based on aggregated 13F filings for Q2 2015.